Daniel S. Lorrain

Amira Pharmaceuticals, Quezon City, Metro Manila, Philippines 
Serotonin's effect on copulation
"Daniel Lorrain"
Mean distance: 14.96 (cluster 59)
Cross-listing: Chemistry Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mei F, Lehmann-Horn K, Shen YA, et al. (2016) Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery. Elife. 5
Mei F, Mayoral SR, Nobuta H, et al. (2016) Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 7925-35
Messmer D, Jacintho J, Lorrain K, et al. (2015) A selective novel Peroxisome-proliferator-activated receptor alpha (PPARα) antagonist induces apoptosis and inhibits proliferation of CLL cells in vitro and in vivo. Molecular Medicine (Cambridge, Mass.)
Bravo Y, Baccei CS, Broadhead A, et al. (2014) Identification of the first potent, selective and bioavailable PPARα antagonist. Bioorganic & Medicinal Chemistry Letters. 24: 2267-72
Stebbins KJ, Broadhead AR, Musiyenko A, et al. (2012) DP2 (CRTh2) antagonism reduces ocular inflammation induced by allergen challenge and respiratory syncytial virus. International Archives of Allergy and Immunology. 157: 259-68
Hama AT, Broadhead A, Lorrain DS, et al. (2012) The antinociceptive effect of the asthma drug ibudilast in rat models of peripheral and central neuropathic pain. Journal of Neurotrauma. 29: 600-10
Stock NS, Bain G, Zunic J, et al. (2011) 5-Lipoxygenase-activating protein (FLAP) inhibitors. Part 4: development of 3-[3-tert-butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic acid (AM803), a potent, oral, once daily FLAP inhibitor. Journal of Medicinal Chemistry. 54: 8013-29
Scott JM, Baccei C, Bain G, et al. (2011) Discovery and optimization of a biphenylacetic acid series of prostaglandin D2 receptor DP2 antagonists with efficacy in a murine model of allergic rhinitis. Bioorganic & Medicinal Chemistry Letters. 21: 6608-12
Bain G, Lorrain DS, Stebbins KJ, et al. (2011) Pharmacology of AM211, a potent and selective prostaglandin D2 receptor type 2 antagonist that is active in animal models of allergic inflammation. The Journal of Pharmacology and Experimental Therapeutics. 338: 290-301
Cortright JJ, Lorrain DS, Beeler JA, et al. (2011) Previous exposure to delta9-tetrahydrocannibinol enhances locomotor responding to but not self-administration of amphetamine. The Journal of Pharmacology and Experimental Therapeutics. 337: 724-33
See more...